Spiramycin

Kathryn Dzintars, Pharm.D., BCPS, Paul G. Auwaerter, M.D.
Spiramycin is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Spiramycin: not commercially available in the U.S.
    • May be obtained as below (see Adult Dosing)
  • Indicated for treating primary toxoplasmosis in pregnant women to prevent congenital toxoplasmosis (IgM titer needs to be confirmed by Dr. Jack S. Remington Laboratory for Specialty Diagnostics; T: 650-853-4828).

NON-FDA APPROVED USES

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Spiramycin: not commercially available in the U.S.
    • May be obtained as below (see Adult Dosing)
  • Indicated for treating primary toxoplasmosis in pregnant women to prevent congenital toxoplasmosis (IgM titer needs to be confirmed by Dr. Jack S. Remington Laboratory for Specialty Diagnostics; T: 650-853-4828).

NON-FDA APPROVED USES

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: October 18, 2022